共 50 条
- [21] Comment on "Associations between the incidence of antiphosphatidylserine and antiphosphatidylethanolamine antibodies and clinical manifestations of systemic lupus erythematosus" reply POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (03): : 208 - 209
- [22] Pertinence of cardiovascular disease risk awareness in adolescent patients with systemic lupus erythematosus: comment on the article by Scalzi et al Reply ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3972 - 3972
- [24] Systemic lupus erythematosus: managing cardiovascular risk factors LANCET RHEUMATOLOGY, 2024, 6 (07): : e415 - e416
- [26] Cardiovascular risk assessment and treatment in systemic lupus erythematosus BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (04): : 481 - 494
- [28] Nutritional aspects and cardiovascular risk in systemic lupus erythematosus REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (05): : 656 - 660
- [30] Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus Seminars in Immunopathology, 2022, 44 : 309 - 324